Although future studies are needed, the proposed link between the type I IFN pathway, G-CSF responsiveness, and the myeloid bias of circulating CD34+ cells provide important pathophysiological insights into their behavior post-engraftment in gene therapy settings as well as their involvement in the initiation and persistence of chronic inflammation in patients with SCA. The gene discussed is CD34; the disease is autosomal dominant cerebellar ataxia.